The effect of preoperative anti-TNF therapy on postoperative infection risk was examined in the PUCCINI trial, in which 947 IBD patients underwent surgery, and anti-TNF use within the previous 12 weeks was reported in 382 individuals [111]. Here, TNF is linked to inflammatory bowel disease.